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Abstract: Ochratoxins are secondary metabolites of Aspergillus and Penicillium, that are 
hazardous to health through contamination of dietary foods. Ochratoxin A (OTA) remains 
the single most potent member of this group of mycotoxins. OTA has a long half-life in 
humans and is thus easily detected in serum. Dietary intake studies have confirmed link 
between endemic nephrotoxicity in humans to their daily household intake of OTA. OTA 
has been reported to contribute to endemic nephrotoxicity and carcinogenicity in humans 
and animals. OTA produces renal tumours, DNA adducts and chromosomal aberrations in 
kidneys. OTA may be embryotoxic, teratogenic, and immunotoxic only at doses higher 
than  those  causing  nephrotoxicity.  The  incidence  of  endemic  nephrotoxicity  has  been 
mostly reported in northeast Europe since the early fifties. Recent studies however have 
warned  that  OTA  and  other  toxins,  such  as  aristolochic  acid,  show  very  similar  renal 
pathology. There is thus the need for thorough co-occurrence studies on toxin incidence. 
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1. Source and Chemical Structure  
Ochatoxins belong to a family of mycotoxins that are secondary metabolites of Aspergillus sp. and 
Penicillium sp. Their growth promoting conditions are delineated in Table 1.  
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Table 1. Growth conditions for ochratoxin production. 
Growth conditions  A. ochraceus  P. verrucosum 
optimum temperature for growth  24 to 37 °C   20 °C  
optimum temperature for ochratoxin production   31 °C   20 °C  
optimum growth pH  3 to 10  6.0 to 7.0 
minimum water activity for ochratoxin production  0.8  0.86 
Several types of ochratoxins occur naturally, namely, ochratoxin A, ochratoxin B (dechlorinated 
OTA) and ochratoxin C (ethylated OTA), and are often co-produced. Ochratoxin A (Figure 1) is the 
most prevalent toxin and is classified as a group 2b potential human carcinogen by the International 
Agency  for  Research  on  Cancer  [1].  Aristolochic  acids  are  phytotoxins  belonging  to  the 
Aristolochiaceae family of plants and have been suspected to induce similar nephrotoxic effects in 
humans and animals [2]. 
Figure 1. Ochratoxin A from Aspergillus sp. 
 
2. Occurrence in Food and Dietary Intake 
Ochratoxins occur primarily in cereals in northern Europe and Africa. A few examples of foods 
containing ochratoxins are listed in Table 2.  
Table 2. Food commodities intoxicated with ochratoxins. 
Food commodity  Country 
Dry beans (5–30 µ g/kg)   Croatia [3] 
Maize (10–50 µ g/kg)   Croatia [2], Bulgaria [4] 
Wheat , wheat bran  Bulgaria [4] 
Barley, oats  Bulgaria [4] 
Wine  South Africa [5] 
Green coffee beans (18–48 μg/kg)  Congo [6] 
Analysis of OTA and citrinin in food and feed samples were performed by enzyme immunoassays, 
which gave detection limits of 0.5 and 5 ng/g, respectively. OTA-values were confirmed by high 
performance liquid chromatography after immunoaffinity chromatography. Vrabcheva and co-workers 
[3] found the highest toxin levels in wheat, wheat bran, and oats. South African wines tested (15 white 
and nine red) were found to contain detectable levels (>0.01 μg/L) of OTA, with a mean of 0.16 μg/L 
in the white wines and a mean of 0.24 μg/L in the red wines [5]. Ochratoxins have also been found in 
meat, dairy and baked products, especially swine sausages and breads [7,8]. In humans a dietary intake Toxins 2010, 2                         
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of 1.21 µ g per day has been linked to endemic nephropathy [7]. Further reports suggest that chronic 
dietary exposure to OTA, a mycotoxin frequently detected in various food items may be linked to the 
pathogenesis  of  endemic  nephropathy,  a  chronic  tubulointerstitial  kidney  disease  which  occurs  in 
geographically limited areas of the Balkan region [8]. Contradictory findings have been reported by 
Mally and co-workers [9]. Based on food consumption data and OTA serum concentrations, they 
suggest that human exposure, even in areas with relatively high dietary exposure to OTA, such as 
endemic  villages,  is  several  orders  of  magnitude  below  doses  known  to  cause  nephrotoxicity  and 
tumour formation in laboratory animals.  
3. Incidence of Disease 
Ochratoxins have been related to human and animal diseases in literature especially since the early 
1970s. Most reports indicate that ochratoxin plagued especially the North Eastern European countries, 
such as Bulgaria, Romania, Serbia, Croatia, Bosnia, Herzegovina, Slovenia, Macedonia, Monte Negro 
and Africa, such as Congo, South Africa, Tunisia, Morocco and Egypt [3–11]. 
4. Detection of Disease-Diagnosis 
The concentration range of OTA in human serum is 5–50 ng/mL and OTA has a long serum half-
life in various species including humans [3]. Schwerdt and others [12] measured OTA concentrations 
in blood of subjects suffering from various renal diseases as e.g. interstitial nephritis or mesangial 
proliferating  glomerular  nephritis  and  compared  these  values  with  those  obtained  from  healthy 
individuals. OTA was detected in 87% of all samples. There was no significant difference between 
OTA concentrations of healthy individuals and patients with chronic glomerular nephritis whose sera 
showed OTA concentration greater than 1.5 nmol/L. In contrast, no values greater than 1.5 nmol/L 
were present in the sera of patients with membranous or focal-sclerotic glomerular nephritis. These 
preliminary results suggest that a serum concentration of OTA greater than 1.5 nmol/L may be a 
biomarker for glomerular nephritis.  
In  May  2000,  Abouzied  and  colleagues  [7],  using  a  competitive  direct  enzyme-lnked 
immunosorbent  assay  for  OTA  (detection  limit  1  μg/kg),  investigated  OTA  contamination  in  165 
samples of home-produced food (beans, potatoes, corn, wheat, flour) and feed from households in 
villages  from  the  Balkan  endemic  nephropathy  region  (Vratza  district)  of  north-western  Bulgaria. 
Samples were collected from: (a) 20 households of Balkan endemic nephropathy villages (n = 8), and 
16 households of Balkan endemic nephropathy-free households (within-village household controls) 
and (b) 22 Balkan endemic nephropathy-free households of Balkan endemic nephropathy-free villages 
and 22 households between-village controls. Balkan endemic nephropathy households consistently had 
a higher proportion of OTA-positive samples than within village control households, but similar (for 
some  foods)  or  lower  (for  other  foods)  amounts  when  compared  between  village  controls.  The 
proportion  of  OTA-positive  samples  was  also  higher  in  household  between  village  controls  when 
compared to those within village controls. Furthermore, Balkan endemic nephropathy households had 
a  similar  number  of  OTA-positive  samples  when  compared  to  the  pooled  values  for  within  and 
between  groups  of  households.  OTA-exposure  estimates,  derived  from  our  OTA-concentration 
findings and the reported average per capita monthly consumption of basic foods in rural Bulgaria, Toxins 2010, 2                         
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showed  the  highest  OTA  intake  in  Balkan  endemic  nephropathy  households  (1.21  μg  per  day),  
vs. 1.03 μg per day in between village control households, and 0.71 μg per day in within village control 
households. This is in agreement with other studies carried out in the same region [4,13]. These OTA 
intakes  are  higher  than  those  reported  in  the  European  Union,  and  are  close  to  the  upper  limits 
acceptable to several food-safety organizations. These data indicate that OTA may not alone cause 
Balkan  endemic  nephropathy  but  synergistically  with  other  environmental  toxicants  and/or 
predisposing genotypes. Peraica et al. [14] recently detected OTA in food collected in the endemic 
areas and in blood and urine of their residents. In Serbia, a survey showed the prevalence of OTA in 
Balkan endemic nephropathy families associated with the presence of citrinin [15].  
5. Toxicity in Animals and Humans 
5.1. Animal toxicity 
Nephrotoxicity: Pigs, being most sensitive to ochratoxins, suffer from porcine nephropathy. Field cases 
of  ochratoxin-induced  nephropathy  in  pigs  have  been  reported  from  many  countries.  Mycotoxic 
porcine nephropathy is recognized as an endemic disease entity also in several northern and central 
European  countries.  Krogh  and  others  [16]  found  epidemics  of  mycotoxic  porcine  nephropathy, 
closely related to excessive climatic conditions, to occur in pigs in the season preceding harvest. Renal 
damage has been induced by alimentary exposure to ochratoxin A in all single-stomach animals tested 
so far, including rodents, dogs, pigs and birds, and even in young ruminants still functioning as single-
stomach animals. Krogh [17] states that most information on ochratoxin-induced nephropathy has been 
obtained in pigs during experimental studies comprising structural as well as functional changes. The 
renal damage is characterized morphologically by atrophy of the proximal tubules, interstitial cortical 
fibrosis and sclerotized glomeruli, and functionally by impairment of tubular function indicated by a 
reduction of maximal tubular excretion of para-aminohippurate per clearance of inulin and an increase 
in glucose excretion. Further, there is reduced ability to produce concentrated urine. The renal effect 
has been observed using exposure levels of OTA in the range 200 to 4,000 μg /kg feed [18].  
Retrospective studies, in the absence of previous exposure data, have been performed on renal 
biopsy  material  to  determine  the  activity  of  two  renal  tubular  enzymes,  phosphoenolpyruvate 
carboxykinase  and  gamma-glutamyl  transpeptidase.  Analysis  of  the  activity  suggested  that  these 
enzymes were sensitive indicators of OTA-induced porcine nephropathy. In pigs exposed to ochratoxin 
A for 1 week a 40% reduction of the enzyme activity was observed. The dose-related activity decrease 
of the two enzymes was accompanied by a dose-related aggravation of renal impairment, as measured 
by a reduction of tubular excretion of para-aminohippurate per clearance of inulin, suggesting that 
these  enzymes  are  sensitive  indicators  of  OTA-induced  nephropathy  [20].Embryotoxicity, 
teratogenicity and immunotoxicity occur only at doses higher than those causing nephrotoxicity [20]. 
 
Carcinogenesis: In female pigs exposed to alimentary ochratoxin A for two years, no renal cancer was 
observed.  OTA  is  metabolized  and  excreted  relatively  fast  in  animals,  with  an  RL50  (residue 
elimination) in the pig of a few days for various tissues [17]. OTA is a recognized renal carcinogen in 
the mouse and rat [1,21,22]. The pathological lesions observed in kidneys of rats treated with OTA Toxins 2010, 2                         
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appear be rather different from the clinical and pathological characteristics of endemic nephropathy 
[19]. As soon as 1991, Pfohl-Leszkowicz et al. [23] demonstrated that OTA binds covalently with 
DNA in mice and also in rats [24]. Male rats appear to be extremely sensitive to OTA due to genetic 
susceptibility linked to biotransformation [25]. Recently, the chemical structure of OTA DNA adduct 
(C-C8dG-OTA) has been demonstrated by MS/MS [26].  
5.2. Human toxicity 
Nephropathy:  In  humans,  ochratoxins  cause  endemic  nephropathy,  which  has  been  described  in 
several  studies  in  North  Eastern  Europe  as  reported  by  Walker  and  Larsen  [27–30].  Possible  
OTA-induced acute renal failure was recently reported in Italy after a farmer and his wife worked eight 
hours in a granary closed for several months. Renal biopsy in the woman who developed nonoliguric 
acute renal failure revealed lesions of acute tubular necrosis [31]. A strain of Aspergillus ochraceus 
producing OTA was isolated from the wheat. Chronic nephrotoxicity due to OTA is probably more 
usual and makes the diagnosis more difficult. Balkan endemic nephropathy, a chronic tubulointerstitial 
renal disease, could be due to OTA. According to Simon [32] epidemiologic studies showed that in 
areas where high OTA levels are reached in food and in the blood of the population, there is a high 
incidence  of  nephropathy  and  renal  tumours.  The  FAO/WHO  Joint  Expert  Committee  on  Food 
Additives indicate a provisional tolerable intake of 14.3 ng/kg bw per day, based on the LOEL for 
renal effects in pigs [29]. The European Scientific Committee on Food indicates a lower tolerable 
intake, below 5 ng/kg bw per day [29].  
 
Liver toxicity: In man OTA exhibits unusual toxicokinetics, with a half-life in blood of 840 h (35 days) 
after oral ingestion. The delayed excretion of the toxin in man may be due to reabsorption during 
enterohepatic  circulation,  reabsorption  from  the  urine  after  tubular  secretion  or  extensive  protein 
binding [33]. Since the toxin is ingested with almost every meal, humans may not be free of toxin for 
very long periods. Liver elimination of OTA is maintained by protein carriers that shuffle the toxin 
from its protein-bound form in blood into the hepatocyte and subsequently secrete the toxin into bile. 
The uptake carrier has been identified but less is known about the mechanism involved in the release 
into bile. A carrier system is also involved in the uptake of OTA by proximal tubule cells, which 
secrete the toxin into urine. Such systems are biological entrance gates that determine the elimination 
toxicokinetics  of  OTA  and  therefore  have  a  major  impact  on  half-life  times  and  selective  organ 
exposure [33]. 
 
Carcinogenesis: Renal tumours often occur on a dietary intake which is greater than 70 µ g /kg bw per 
day of OTA. Individuals in the endemic region of the Balkan countries exposed to OTA developed 
DNA adducts in renal tissue and tumours [15,34,35]. Karyomegalic interstitial nephritis, characterized 
by karyomegaly in proximal and distal tubular epithelial cells, has been reported in nine patients by 
using a new molecular epidemiological approach [32]. Karyomegaly could be due to an environmental 
toxin that interferes with DNA replication. Involvement of the oxidative pathway in genotoxicity of 
OTA  is  known  and  oxidant  stress  induces  DNA  damage,  according  to  Palma  and  others  [36]. 
Therefore, karyomegaly could be a histological marker of interstitial nephritis due to OTA as outlined Toxins 2010, 2                         
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by Dietrich and Swenberg [37]. In a carcinogenic study it has been demonstrated that the mechanism 
by  which  OTA  induced  nephrotoxicity  (notably  reflected  by  karyomegalies)  is  different  from 
cacrcinogenicity  [38].  Recently  Manderville  and  Pfohl-Leszkowicz  [39]  explained  how  oxidative 
pathway lead to OTA genotoxicity. 
6. Co-Occurrence of Nephrotoxins 
Studies have reported that the pathological changes produced by aristolochic acid are comparable to 
those produced by OTA [2]. There is therefore the need for toxin co-occurrence studies involving 
citrinin, fumonisin, aristolochic acid and OTA. Co-contamination of ochratoxin A and citrinin was 
found in varying number of households in two Balkan villages. Citrinin levels in those samples were 
clearly higher than those of OTA [15,35]. Data on the co-occurrence in food of OTA and other toxic 
mycotoxins such  as  citrinin  and  fumonisin B1 have  been reported also [8,14].  Cultured  cells  and 
laboratory animals treated with combinations of OTA and other nephrotoxins, show synergistic effects 
[8]. The occurrence of OTA- and either citrinin or fumonisin increased genotoxicity [14,35].  
7. Concluding Remarks 
Despite many efforts, the aetiology of endemic nephropathy is still unknown [14]. This disease 
occurs in the rural population of geographically limited areas of Bulgaria, Bosnia and Herzegovina, 
Croatia, Romania, and Serbia, and a number of theories have been proposed about its aetiology. The 
mycotoxin theory has prevailed until now, based on the studies of nephrotoxic mycotoxin OTA that 
revealed higher frequency of OTA-positive food and blood samples in endemic than in non-endemic 
Balkan areas. However, recently it has been suggested that aristolochic acid is the aetiological cause of 
endemic  nephropathy,  because  of  the  histological  similarities  in  kidney  lesions  between  patients 
suffering from endemic nephropathy and patients suffering from Chinese herbs nephropathy caused by 
aristolochic acid. Until now it has not been unequivocally proved that the inhabitants of endemic 
nephropathy areas are exposed to higher concentration of aristolochic acid than in other regions and 
the exposure pathways are rather uncertain. There is a paradox between the wide distribution of OTA 
throughout the world with the expected risk of OTA causing human renal disease and the rarity of 
reported  cases  demonstrating  its  role  in  chronic  renal  disease  [32].  OTA  and  probably  other 
mycotoxins could be major environmental factors in the occurrence of renal disease especially in 
developing countries according to Tatu and co-workers [40]. Some studies have found a geographic 
co-variation between OTA content in food/feed and Balkan endemic nephropathy manifestation; others 
have not [7]. The Romanian group [40] mention two actually competing theories attempting to explain 
the cause of Balkan endemic nephropathy: (1) the mycotoxin hypothesis, which considers that Balkan 
endemic nephropathy is produced by ochratoxin A ingested intermittently in small amounts by the 
individuals in the endemic regions, and (2) the Pliocene lignite hypothesis, which proposes that the 
disease is caused by long-term exposure to polycyclic aromatic hydrocarbons and other toxic organic 
compounds leaching into the well drinking water from low rank coals underlying or proximal to the 
endemic settlements. In this review we have outlined the current knowledge on ochratoxins. Future 
studies need to focus on possible factors and co-factors involved in aetiology of OTA renal disease  
and cancer. Toxins 2010, 2                         
 
 
777 
References and Notes 
1.  International Agency for Research on Cancer. Some Naturally Occurring Substances: Some Food 
Items and Constituents, Heterocyclic Aromatic Amines and Mycotoxins. In IARC Monographs on 
the Evaluation of Carcinogenic Risks to Humans; IARC: Lyon, France, 1993; Volume 56.  
2.  Peraica,  M.;  Domijan,  A.M.;  Sarić,  M.  Mycotoxic  and  aristolochic  acid  theories  of  the 
development of endemic nephropathy. Arh Hig Rada Toksikol. 2008, 59 (1), 59–65. 
3.  Radic, B.; Fuchs, R.; Peraica, M.; Lucic, A. Ochratoxin A in human sera in the area with endemic 
nephropathy in Croatia. Toxicol. Lett. 1997, 91, 105–109.  
4.  Vrabcheva,  T.;  Usleber,  E.;  Dietrich,  R.;  Mä rtlbauer,  E.  Co-occurrence  of  ochratoxin  A  and 
citrinin in cereals from Bulgarian villages with a history of Balkan endemic nephropathy. J. Agric. 
Food Chem. 2000, 48 (6), 2483–2488. 
5.  Shephard,  S.;  Fabiani,  A.;  Stockenströ m,  S.;  Mshicileli,  N.;  Sewram,  V.  Quantitation  of 
ochratoxin A in South African wines. J. Agric. Food Chem. 2003, 51 (4), 1102–1106. 
6.  Romani,  S.;  Sacchetti,  G.;  Ló pez,  C.C.;  Pinnavaia,  G.G.;  Dalla  Rosa,  M.  Screening  on  the 
occurrence of ochratoxin A in green coffee beans of different origins and types. J. Agric. Food 
Chem. 2000, 48 (8), 3616–3619. 
7.  Abouzied,  M.M.;  Horvath,  A.D.;  Podlesny,  P.M.;  Regina,  N.P.;  Metodiev,  V.D.;  
Kamenova-Tozeva,  R.M.;  Niagolova,  N.D.;Stein,  A.D.;  Petropoulos,  E.A.;  Ganev,  V.S. 
Ochratoxin A concentrations in food and feed from a region with Balkan Endemic Nephropathy. 
Food Addit. Contam. 2002, 19 (8), 755–764. 
8.  Pfohl-Leszkowicz, A.; Manderville, R. Review on Ochratoxin A: an overview on toxicity and 
carcinogenicity in animals and humans. Mol. Nutr. Food Res. 2007, 51, 61–99.  
9.  Mally,  A.;  Hard,  G.C.;  Dekant,  W.  Ochratoxin  A  as  a  potential  etiologic  factor  in  endemic 
nephropathy:  lessons  from  toxicity  studies  in  rats.  Food  Chem.  Toxicol.  2007,  45  (11),  
2254–2260.  
10.  Krogh, P. Mycotoxic porcine nephropathy–a possible model for Balkan (endemic) nephropathy. 
In  Endemic  Nephropathy;  Proceedings  of  the  Second  International  Symposium  on  Endemic 
Nephropathy; Bulgarian Academy of Sciences: Sofia, Bulgaria, 1972; pp. 266–277. 
11.  Chernozemsky, I.N.; Stoyanov, I.S.; Petkova-Bocharova, T.K.; Nikolov, I.G.; Draganov, I.V.; 
Stoichev, I.T.; Tanchev, Y.; Naidenov, D.; Kalcheva, N.D. Geographic correlation between the 
occurrence of endemic nephropathy and urinary tract tumours in Vratza district Bulgaria. Int. J. 
Cancer 1977, 19, 1–11. 
12.  Schwerdt,  G.;  Schuster,  C.;  Silbernagl,  S.;  Gareis,  M.;  Gekle,  M.  Preliminary  results  on 
Ochratoxin  A  concentrations  in  blood  of  patients  with  various  kidney  diseases  in  Germany. 
Mycotoxin Res. 2001, 17 (2), 146–149. 
13.  Petkova-Bocharova, T.; Castegnaro, M.; Pfohl-Leszkowicz, A.; Garren, L.; Grosso, F.; Nikolov, 
I.; Vrabcheva, T.; Dragacci, S.; Chernozemsky, I. Analysis of ochratoxin A in serum and urine of 
inhabitants from an area with Balkan Endemic Nephropathy: A one month follow up study. Facta 
universitatis series: medicine and biology 2003, 10 (2), 62–68. 
14.  Peraica, M.; Domijan, A.M.; Miletić-Medved, M.; Fuchs, R. The involvement of mycotoxins in 
the development of endemic nephropathy. Wien Klin Wochenschr. 2008, 120 (13–14), 402–407. Toxins 2010, 2                         
 
 
778 
15.  Pfohl-Leszkowicz, A.; Tozlovanu, M.; Manderville R.; Peraica, M.; Castegnaro, M.; Stefanovic, 
V. New molecular and field evidences for the implication of mycotoxins but not aristolochic acid 
in Human Nephropathy and Urinary tract tumor. Mol. Nutr. Food Res. 2007, 51, 131–146. 
16.  Krogh, P.; Elling, F.; Friis, C.; Hald, B.; Larsen, A.E.; Lillehø j, E.B.; Madsen, A.; Mortensen, 
H.P.;  Rasmussen,  F.;  Ravnskov,  U.  Porcine  nephropathy  induced  by  long-term  ingestion  of 
ochratoxin A. Vet. Pathol. 1979, 16 (40), 466–475.  
17.  Krogh, P. Role of ochratoxin in disease causation. Food Chem Toxicol. 1992, 30 (3), 213–224. 
18.  Stoev,  S.D.;  Paskalev,  M.;  MacDonald,  S.;  Mantle,  P.G.  Experimental  1  year  ochratoxin  A 
toxicosis in pigs. Exp. Toxicol. Pathol. 2002, 53, 481–487. 
19.  Stoev, S.D. The role of ochratoxin A as a possible cause of Balkan endemic nephropathy and its 
risk evaluation. Vet. Human Toxicol. 1998, 40, 352–360. 
20.  Benford, D.; Boyle, B.; Dekant, W.; Fuchs, R.; Gaylor, D.W.; Hard, G.; McGregor, D.B.; Pitt, 
J.I.; Plestina, R.; Shephard, G.; Solforizzo, M.; Verger, P.J.P; Walker, R. Ochratoxin A. JECFA 
2001, 47, 1–172. 
21.  Castegnaro, M.; Mohr, U.; Pfohl-Leszkowicz, A.; Estè ve, J.; Steinmann, J.; Tillman, J.; Michelon, 
J.; Bartsch, H. Sex and Strain-specific induction of renal tumours by ochratoxin A rats correlates 
with DNA adduction. Int. J. Cancer 1998, 77, 70–75. 
22.  Mantle, P.; Kulinskaya, E.; Nestler, S. Renal tumourigenesis in male rats in response to chronic 
dietary ochratoxin A. Food Add Contam. 2005, 22 (1), 58–64. 
23.  Pfohl-Leszkowicz, A.; Chakor, K.; Creppy, E.E.; Dirheimer, G. DNA-adducts formation after 
treatment of mice with ochratoxin A. In Mycotoxins, Endemic Nephropathy and Urinary Tracts 
Tumours; IARC Scientific Publication: Lyon, France, 1991; Volume 115, pp. 245–253. 
24.  Pfohl-Leszkowicz,  A.;  Grosse,  Y.;  Kane,  A.;  Creppy,  E.E.;  Dirheimer,  G.  Differential  DNA 
adduct  formation  and  disappearance  in  three  mice  tissues  after  treatment  by  the  mycotoxin, 
ochratoxin A. Mut. Res. 1993, 289, 265–273. 
25.  Pfohl-Leszkowicz,  A.;  Pinelli,  E.;  Bartsch,  H.;  Mohr,  U.;  Castegnaro,  M.  Sex  and  Strain 
differences in ochratoxin A metabolism and DNA adduction in two strains of rats. Mol. Carcinog. 
1998, 23, 76–83. 
26.  Mantle, P.; Faucet-Marquis, V.; Manderville, R.; Sciqualli, B.; Pfohl-Leszkowicz, A. Structures 
of covalent adducts between DNA and ochratoxin A: a new factor in debate about genotoxicity 
and human risk assessment. Chem. Res. Toxicol. 2010, 23, 89–98. 
27.  Stefanovic, V.; Polenakovic, M.H. Balkan nephropathy. Am. J. Nephrol. 1991, 11, 1–11. 
28.  Vukelic, M.; Sostaric, B.; Belicza, M. Pathomorphology of Balkan endemic nephropathy. Food 
Chem. Toxicol. 1992, 30, 193–200. 
29.  Walker, R.; Larsen, J.C. Ochratoxin A: previous risk assessments and issues arising. Food Addit. 
Contam. 2005, Suppl., 6–9.  
30.  Fuchs, R.; Peraica, M. Ochratoxin A in human kidney diseases. Food Addit. Contam. 2005, 22 
(1), 53–57.  
31.  Di Paolo, N.; Guarnieri, A.; Loi, F.; Sacchi, G.; Mangiarotti, A.M.; Di. Paolo, M. Acute renal 
failure from inhalation of mycotoxins. Nephron 1993, 64, 621–625. 
32.  Simon, P. Ochratoxin and Kidney Disease in the Human. Toxin Rev. 1996, 15 (3), 239–249. Toxins 2010, 2                         
 
 
779 
33.  Petzinger, E.; Weidenbach, A. Mycotoxins in the food chain: the role of ochratoxins. Livestock 
Prod. Sci. 2002, 76 (3), 245–250. 
34.  Pfohl-Leszkowicz,  A.;  Grosse,  Y.;  Castegnaro,  M.;  Petkova-Bocharova,  T.;  Nicolov,  I.G.; 
Chernozemsky, I.N.; Bartsch, H.; Betbeder, A.M.; Creppy, E.E.; Dirheimer, G. Ochratoxin A 
related DNA adducts in urinary tract tumours of Bulgarian subjects. In Postlabelling methods for 
detection  of  DNA  adducts;  IARC  Scientific  Publication:  Lyon,  France,  1993;  Volume  124,  
pp. 141–148. 
35.  Pfohl-Leszkowicz,  A.  Ochratoxin  A  and  aristolochic  acid  involvement  in  nephropathies  and 
associated urothelial tract tumours. Arhiv za higijenu rada i toksikologiju 2009, 60 (4), 465–483. 
36.  Palma, N.; Cinelli, S.; Sapora, O.; Wilson, S.H.; Dogliotti, E. Ochratoxin A-induced mutagenesis 
in mammalian cells is consistent with the production of oxidative stress. Chem. Res. Toxicol. 
2007, 20 (7), 1031–1037. 
37.  Dietrich, D.R.; Swenberg, J.A. Renal Carcinogenesis. In Toxicology of the Kidney; Hook, J.B., 
Goldstein, R., Eds.; Raven Press: New York, NY, USA, 1993; Volume 19, pp. 495–537. 
38.  Pfohl-Leszkowicz,  A.;  Petkova-Bocharova,  T.;  Chernozemsky,  I.N.;  Castegnaro,  M.  Balkan 
endemic  nephropathy  and  the  associated  urinary  tract  tumours:  review  on  etiological  causes, 
potential role of mycotoxins. Food Add. Contam. 2002, 19 (3), 282–302. 
39.  Manderville,  R.;  Pfohl-Leszkowicz,  A.  Bioactivation  and  DNA  Adduction  as  a  Rationale  for 
Ochratoxin A Carcinogenesis. World Mycotoxin J. 2008, 1 (3), 357–367. 
40.  Tatu,  C.A.;  Orem,  W.H.;  Finkelman,  R.B.;  Feder,  G.L.  The  etiology  of  Balkan  endemic 
nephropathy:  still  more  questions  than  answers.  Environ.  Health  Perspect.  1998,  106  (11),  
689–700. 
©  2010  by  the  authors;  licensee  MDPI,  Basel,  Switzerland.  This  article  is  an  open-access  article 
distributed  under  the  terms  and  conditions  of  the  Creative  Commons  Attribution  license 
(http://creativecommons.org/licenses/by/3.0/). 